Fulcrum Therapeutics (FULC) Long-Term Debt Repayments (2018 - 2021)
Fulcrum Therapeutics (FULC) reported Long-Term Debt Repayments of $1000.0 for Q4 2021, down 92.31% year-over-year from $13000.0 in Q4 2020, and up 200.0% quarter-over-quarter from -$1000.0 in Q3 2021.
Fulcrum Therapeutics (FULC) Long-Term Debt Repayments (2018 - 2021) Analysis & Trends
Fulcrum Therapeutics (FULC) has 4 years of Long-Term Debt Repayments data on file, last reported at $1000.0 in Q4 2021.
- Long-Term Debt Repayments for Q4 2021 came in at $1000.0, down 92.31% year-over-year; the trailing twelve-month figure through Sep 2022 was $1000.0 (down 96.67% YoY), and the FY2021 annual result was $18000.0, down 64.0% from the prior year.
- Long-Term Debt Repayments advanced to $1000.0 in Q4 2021 per FULC's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at $13000.0 in Q3 2019 and troughed at -$1000.0 in Q3 2021.
- A 4-year average of $9571.4 and a median of $11000.0 in 2018 frame the typical range for Long-Term Debt Repayments.
- The sharpest annual moves came in 2019 and 2021: Long-Term Debt Repayments soared 30.0% in 2019, then sank 107.69% in 2021.
- A 4-year view of Long-Term Debt Repayments shows it stood at $11000.0 in 2018, then changed by 0.0% to $11000.0 in 2019, then climbed by 18.18% to $13000.0 in 2020, then tumbled by 92.31% to $1000.0 in 2021.
- Business Quant data shows FULC's Long-Term Debt Repayments at $1000.0 in Q4 2021, -$1000.0 in Q3 2021, and $5000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Fulcrum Therapeutics | 267.90 Mn | 267.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 12,000.00 |
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Sep 30, 2019 | 13,000.00 |
| Sep 30, 2019 | 13,000.00 |